Detection of cancer cells in the cerebrospinal fluid: current methods and future directions
2011

Detecting Cancer Cells in Cerebrospinal Fluid

publication Evidence: moderate

Author Information

Author(s): Weston Cody L, Glantz Michael J, Connor James R

Primary Institution: Penn State University M.S. Hershey Medical Center

Hypothesis

Improved detection methods for cancer cells in cerebrospinal fluid (CSF) are needed due to the limitations of current techniques.

Conclusion

Emerging technologies show promise for more effective detection of cancer cells in the CSF, which is crucial for timely treatment.

Supporting Evidence

  • CSF cytology is the gold standard but has low sensitivity.
  • Flow cytometry has shown higher sensitivity compared to cytology.
  • Emerging technologies like quantum dots and magnetic nanoparticles are being explored for in vivo detection.

Takeaway

Doctors are trying to find better ways to spot cancer cells in the fluid around the brain and spine, which can help treat patients faster.

Methodology

The review discusses various methods for detecting cancer cells in CSF, including cytology, immunocytochemistry, flow cytometry, and genetic detection techniques.

Potential Biases

Potential for false negatives and positives in cytology and flow cytometry due to sample handling and low cell counts.

Limitations

Current methods lack sensitivity and can lead to delays in diagnosis and treatment.

Statistical Information

P-Value

0.002

Statistical Significance

p=0.002

Digital Object Identifier (DOI)

10.1186/2045-8118-8-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication